MohammadRKhayaliMD

PubMed

• Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
  Lieberman, A. N., Kupersmith, M., Neophytides, A., Gopinathan, G., Casson, I., Durso, R., Foo, S. H., Khayali, M., Tartaro, T., Goldstein, M.> ;Adv Biochem Psychopharmacol. 1980
• Long-term efficacy of bromocriptine in Parkinson disease.
  Lieberman, A., Kupersmith, M., Neophytides, A., Casson, I., Durso, R., Foo, S. H., Khayali, M., Bear, G., Goldstein, M.> ;Neurology. 1980 May
• Bromocriptine mesylate in Parkinson''s disease.
  Lieberman, A., Kupersmith, M., Neophytides, A., Casson, I., Durso, R., Foo, S. H., Khayali, M., Tartaro, T.> ;N Y State J Med. 1979 Oct
• Huntington''s disease.
  Lieberman, A., Neophytides, A., Casson, I., Durso, R., Foo, S. H., Khayali, M., Tartaro, T.> ;N Y State J Med. 1979 Jul
• Treatment of Parkinson''s disease with dopamine agonists: a review.
  Lieberman, A., Neophytides, A., Kupersmith, M., Casson, I., Durso, R., Foo, S. H., Khayali, M., Tartaro, T., Goldstein, M.> ;Am J Med Sci. 1979 Jul 01
• Join now to see all